Internet-based Support for Adjustment to Prostate Cancer (ISAC) - A Randomized Controlled Trial of ICBT for Distress Related to Prostate Cancer

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The study aims to study the efficacy of internet-based cognitive behavior therapy (ICBT) in reducing subjective distress and comorbid psychiatric symptoms in men diagnosed with prostate cancer. Participants who have been diagnosed with prostate cancer and are currently not undergoing or scheduled to undergo medical treatment will be recruited. Once recruited, they will be randomized to receive either a tailored, eight-week long ICBT intervention or an attention control group. Both group receive weekly support by a trained therapist.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:

• Subjectively reported psychological symptoms and problems that have come about after a prostate cancer diagnosis.

• A sum score above 19 on the primary outcome measure (Kessler-10).

• An age of 18 or older.

• Ability to speak, read, and write Swedish.

• Access to a computer/laptop/tablet/smartphone and internet access.

• Sufficient computer profiency to be able to use the treatment platform.

Locations
Other Locations
Sweden
Department of Behavioral Sciences and Learning
RECRUITING
Linköping
Contact Information
Primary
Gerhard Andersson, Ph.D.
gerhard.andersson@liu.se
+46-13285840
Backup
Anton Käll, Ph.D.
anton.kall@liu.se
Time Frame
Start Date: 2025-01-05
Estimated Completion Date: 2026-12
Participants
Target number of participants: 180
Treatments
Experimental: Tailored ICBT
An eight week long ICBT treatment that is tailored to the problem profile of the participant. The treatment is modular, with one module being administered per week of the treatment.
Active_comparator: Non-directive support
The control group will receive weekly support via contact with a therapist, without receiving access to the treatment modules.
Related Therapeutic Areas
Sponsors
Collaborators: University Hospital, Linkoeping
Leads: Linkoeping University

This content was sourced from clinicaltrials.gov